publication venue for
- The New Science and Concepts That Underlie Current and Future Treatments for Myeloproliferative Neoplasms.. 35. 2021
- Mantle Cell Lymphoma: Biologic Insights to Bedside Impact.. 34. 2020
- The Management of Esophagogastric Cancers Enters a New Era.. 31. 2017
- Colorectal cancer.. 29. 2015
- Non-CML myeloproliferative diseases. Preface.. 26. 2012
- Developing Precision Medicine for Bladder Cancer. 2021
- Thrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms. 2021
- Approach to the Initial Treatment of Older Patients with Mantle Cell Lymphoma. 2020
- Cell Cycle Dysregulation in Mantle Cell Lymphoma: Genomics and Therapy. 2020
- Watch and Wait in Mantle Cell Lymphoma. 2020
- CD123 as a Therapeutic Target Against Malignant Stem Cells. 2020
- The Clinical Management of Clonal Hematopoiesis: Creation of a Clonal Hematopoiesis Clinic. 2020
- Transfusion Management in Pediatric Oncology Patients. 2019
- Identification and Targeting of Kinase Alterations in Histiocytic Neoplasms. 2017
- Uncommon Variants of T-Cell Lymphomas. 2017
- Future Directions in Improving Outcomes for Patients with Gastric and Esophageal Cancer. 2017
- The Gastric Microbiome and Its Influence on Gastric Carcinogenesis: Current Knowledge and Ongoing Research. 2017
- The Role of Radiotherapy in Localized Esophageal and Gastric Cancer. 2017
- Diagnosis and Treatment of Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer. 2017
- Novel Therapeutics for Pancreatic Adenocarcinoma. 2015
- Mouse Models of Pancreatic Ductal Adenocarcinoma. 2015
- Ablative and catheter-directed therapies for colorectal liver and lung metastases. 2015
- Diagnosis and management of upper tract urothelial carcinoma. 2014
- First-line treatment and prognostic factors of metastatic bladder cancer for platinum-eligible patients. 2014
- Stem cell transplantation in Hodgkin lymphoma. 2014
- Treatment of transplant-eligible patients with multiple myeloma in 2014. 2014
- Immune checkpoint blockade. 2014
- Treatments for noncutaneous melanoma. 2014
- Radiation therapy for duct carcinoma in situ: who needs radiation therapy, who doesn't? 2013
- Parathyroid carcinoma: challenges in diagnosis and treatment. 2012
- Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms. 2012
- Tyrosine kinase inhibitors in lung cancer. 2012
- Contemporary quality of life issues affecting gynecologic cancer survivors. 2011
- Cellular therapies in acute lymphoblastic leukemia. 2011
- Curing all patients with acute promyelocytic leukemia: are we there yet? 2011
- Current surgical management of ovarian cancer. 2011
- Clinical implications of novel mutations in epigenetic modifiers in AML. 2011
- The role of surgery in the management of early-stage renal cancer. 2011
- Mouse models of inherited cancer syndromes. 2010
- Clinical genetics of hereditary colorectal cancer. 2010
- Genitourinary cancer predisposition syndromes. 2010
- Upper gastrointestinal cancer predisposition syndromes. 2010
- Traditional and new approaches to the management of immune thrombocytopenia: issues of when and who to treat. 2009
- Applications of genomics in melanoma oncogene discovery. 2009
- Melanoma early detection. 2009
- The history and future of chemotherapy for melanoma. 2009
- Cancer survivorship: facing forward. 2008
- Long-term cardiac and pulmonary complications of cancer therapy. 2008
- Promoting a healthy lifestyle among cancer survivors. 2008
- Immune thrombocytopenic purpura. 2007
- Bevacizumab for advanced breast cancer. 2007
- Emerging targeted therapies for breast cancer. 2007
- DNA vaccines against cancer. 2006
- Immunotherapy of melanoma. 2006
- Treatment-related neurotoxicity. 2005
- Ewing's sarcoma and primitive neuroectodermal family of tumors. 2005
- Antiangiogenic therapy for primary and metastatic brain tumors. 2004
- Nonmyeloablative stem cell transplantation for chronic myeloid leukemia. 2004
- Chronic myeloid leukemia. 2003
- Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. 2003
- Pathogenesis of Kaposi's sarcoma. 2003
- Affective disorders in advanced cancer. 2002
- Monoclonal antibody-based therapy of neuroblastoma. 2001
- Etiology and pathogenesis of AIDS-related non--Hodgkin's lymphoma. 1996
- The use of tumor markers in germ cell malignancies. 1994
- Changing patterns of infections in the immunocompromised patient with cancer. 1993
- The current role of radiotherapy in the management of ovarian cancer. 1992
- Chemotherapy for metastatic bladder cancer. 1992
- Chemotherapy for muscle-infiltrating bladder cancer. 1992
- Intravesical therapy. 1992
- Chromosomal aberrations in non-Hodgkin's lymphoma. Biologic and clinical correlations. 1991
- Chronic myeloid leukemia. A perspective of the clinical and biologic issues of the chronic phase. 1990
- Autoimmune thrombocytopenic purpura. 1990
- Thrombocytosis and thrombocythemia. 1990
- Granulocyte colony-stimulating factor: preclinical and clinical studies. 1989
- Acute lymphoblastic leukemia of childhood. 1987
- Intraocular and extraocular retinoblastoma. 1987
- Malignant bone tumors in children: Ewing's sarcoma. 1987
- Malignant bone tumors in children: osteosarcoma. 1987
- Intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura in childhood and adolescence. 1987
- Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia. 2023
- Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia. 2023
- Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms. 2021
- Epigenetic Dysregulation of Myeloproliferative Neoplasms. 2021
- Gene Therapy and Genome Editing. 2018
- Autologous Stem Cell Mobilization and Collection. 2016
- Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors. 2015
- Diagnosis and management of DNA mismatch repair-deficient colorectal cancer. 2015
- Surgical management of hepatic metastases of colorectal cancer. 2015
- Future directions and targeted therapies in bladder cancer. 2014
- Chimeric antigen receptor therapy for chronic lymphocytic leukemia: what are the challenges? 2013
- Low-grade gliomas: when and how to treat. 2012
- Management of brain metastases: surgery, radiation, or both? 2012
- Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era. 2011
- mTOR inhibitors in advanced renal cell carcinoma. 2011
- A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors. 2011
- Genome-wide association studies of cancer predisposition. 2010
- Inherited predisposition to cancer: introduction and overview. 2010
- Inherited predisposition to gastrointestinal stromal tumor. 2009
- New biologic agents and immunologic strategies. 2008
- Treatment of primary central nervous system lymphoma. 2005
- Development of matrix metalloproteinase inhibitors in cancer therapy. 2002